Development of self-microemulsifying lipid-based formulations of trans-resveratrol by systematically constructing lipid-surfactant-water phase diagrams using long-chain lipids

References

• Feeney OM, Crum MF, McEvoy CL, et al. 50years of oral lipid-based formulations: provenance, progress and future perspectives. Adv Drug Deliv Rev. 2016;101:167–194.
   PubMed Web of Science ®Google Scholar
• Strickley R. Solubilizing excipients in oral and injectable formulations. Pharm Res. 2004;21(2):201–230.
   PubMed Web of Science ®Google Scholar
• Vonderscher J, Meinzer A. Rationale for the development of Sandimmune Neoral. Transplant. Proc. 1994; 26(5):2925–2927.
   Google Scholar
• Cannon J, Long M. Emulsions, microemulsions, and lipid- based drug delivery systems for drug solubilization and delivery— Part II: Oral applications. In: R. Liu, editor. Water-insoluble Drug Formulations. Boca Raton: CRC; 2018. p. 247–282.
   Google Scholar
• Pouton C, Porter C. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60(6):625–637.
   PubMed Web of Science ®Google Scholar
• Müllertz A, Ogbonna A, Ren S, et al. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J Pharm Pharmacol. 2010;62(11):1622–1636.
   PubMed Web of Science ®Google Scholar
• Nardin I, Köllner S. Successful development of oral SEDDS: screening of excipients from the industrial point of view. Adv Drug Deliv Rev. 2019;142:128–140.
   PubMed Web of Science ®Google Scholar
• Ahmed K, Li Y, McClements D, et al. Nanoemulsion-and emulsion-based delivery systems for curcumin: Encapsulation and release properties. Food Chem. 2012;132(2):799–807.
   Web of Science ®Google Scholar
• Prajapati HN, Patel DP, Patel NG, et al. Effect of difference in fatty acid chain lengths of medium-chain lipids on lipid-surfactant-water phase diagrams and drug solubility. J Excipients Food Chem [Internet]. 2011;2:73–88.
   Google Scholar
• Porter C, Kaukonen A, Taillardat-Bertschinger A, et al. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J Pharm Sci. 2004;93(5):1110–1121.
   PubMed Web of Science ®Google Scholar
• Williams H, Sassene P, Kleberg K, et al.; LFCS Consortium. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations. Pharm Res. 2013;30(12):3059–3076.
   PubMed Web of Science ®Google Scholar
• McEvoy C, Trevaskis N, Edwards G, et al. In vitro-in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623. Eur J Pharm Biopharm. 2014;88(3):973–985.
   PubMed Web of Science ®Google Scholar
• Behrens D, Fricker R, Bodoky A, et al. Comparison of cyclosporin A absorption from LCT and MCT solutions following intrajejunal administration in conscious dogs. J Pharm Sci. 1996;85(6):666–668.
   PubMed Web of Science ®Google Scholar
• Grove M, Müllertz A, Nielsen JL, et al. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur J Pharm Sci. 2006;28(3):233–242.
   PubMed Web of Science ®Google Scholar
• Desai HH, Bu P, Shah AV, et al. Evaluation of cytotoxicity of self-emulsifying formulations containing long-chain lipids using caco-2 cell model: superior safety profile compared to medium-chain lipids. J Pharm Sci. 2020;109(5):1752–1764.
   PubMed Web of Science ®Google Scholar
• Singh G, Pai RS. Recent advances of resveratrol in nanostructured based delivery systems and in the management of HIV/AIDS. J Control Release. 2014;194:178–188.
   PubMed Web of Science ®Google Scholar
• Shah A, Desai H, Thool P, et al. Development of self-microemulsifying drug delivery system for oral delivery of poorly water-soluble nutraceuticals. Drug Dev Ind Pharm. 2018;44(6):895–901.
   PubMed Web of Science ®Google Scholar
• Sandhir R, Yadav A, Sunkaria A, et al. Nano-antioxidants: an emerging strategy for intervention against neurodegenerative conditions. Neurochem Int. 2015;89:209–226.
   PubMed Web of Science ®Google Scholar
• Zupančič Š, Lavrič Z, Kristl J. Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature. Eur J Pharm Biopharm. 2015; 93:196–204.
   PubMed Web of Science ®Google Scholar
• Machado N, Fernández M, Díaz D. Recent strategies in resveratrol delivery systems. Chempluschem. 2019;84(7):951–973.
   PubMed Web of Science ®Google Scholar
• Aloisio C, Bueno MS, Ponte PM, et al. Development of solid self-emulsifying drug delivery systems (SEDDS) to improve the solubility of resveratrol. Ther Deliv. 2019;10(10):626–641.
   PubMed Web of Science ®Google Scholar
• Bolko K, Zvonar A, Gašperlin M. Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility. Drug Dev Ind Pharm. 2014;40(1):102–109.
   PubMed Web of Science ®Google Scholar
• Guil-Guerrero J, Belarbi E. Purification process for cod liver oil polyunsaturated fatty acids. J Amer Oil Chem Soc. 2001;78(5):477–484.
   Web of Science ®Google Scholar
• Von Schacky C, Fischer S, Weber P. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest. 1985;76(4):1626–1631.
   PubMed Web of Science ®Google Scholar
• Galarraga B, Ho M, Youssef H, et al. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology (Oxford). 2008;47(5):665–669.
   PubMed Web of Science ®Google Scholar
• Pouton C. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29(3-4):278–287.
   PubMed Web of Science ®Google Scholar
• Chen F, Etzler F, Ubben J, et al. Effects of lipophilic components on the compatibility of lipid-based formulations with hard gelatin capsules. J Pharm Sci. 2010;99(1):128–141.
   PubMed Web of Science ®Google Scholar
• Prajapati HN, Dalrymple DM, Serajuddin ATM. A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development. Pharm Res. 2012;29(1):285–305.
   PubMed Web of Science ®Google Scholar
• Patel D, Li P, Serajuddin A. Enhanced microemulsion formation in lipid-based drug delivery systems by combining mono-esters of mediumchain fatty acids with di-or tri-esters. J Excipients Food Chem. 2016;3:1113.
   Google Scholar
• Shah A, Thool P, Sorathiya K, et al. Effect of different polysorbates on development of self-microemulsifying drug delivery systems using medium chain lipids. Drug Dev Ind Pharm [Internet]. 2018;44(2):215–223..
   PubMed Web of Science ®Google Scholar
• Li P, Ghosh A, Wagner RF, et al. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm. 2005;288(1):27–34.
   PubMedGoogle Scholar
• Prajapati H, Dalrymple D, Serajuddin A. In vitro dispersion test that could serve as a predictive method for assessing performance of lipid-based drug delivery systems. J Excipients Food Chem. 2013;4:111–125.
   Google Scholar
• López-Nicolás JM, García-Carmona F. Aggregation state and pKa values of (E)-resveratrol as determined by fluorescence spectroscopy and UV-visible absorption . J Agric Food Chem. 2008;56(17):7600–7605.
   PubMed Web of Science ®Google Scholar
• CDER/FDA. Guidance for Industry, Waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system [Internet]. Cent. Drug Eval. Res. 2017; Available from: http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Guidance+for+Industry+Waiver+of+In+Vivo+Bioavailability+and+bioequivalence+studies#0.
   Google Scholar
• Amidon GL, Lennernäs H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413–420.,.
   PubMed Web of Science ®Google Scholar
• Robinson K, Mock C, Liang D. Pre-formulation studies of resveratrol. Drug Dev Ind Pharm. 2015;41(9):1464–1469.
   PubMed Web of Science ®Google Scholar
• Walle T, Hsieh F, DeLegge MH, et al. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32(12):1377–1382.
   PubMed Web of Science ®Google Scholar
• Rane SS, Anderson BD. What determines drug solubility in lipid vehicles: Is it predictable? Adv Drug Deliv Rev. 2008;60(6):638–656.
   PubMed Web of Science ®Google Scholar